ProKidney Corp.
PROK
$1.08
$0.054.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -72.51% | -25.80% | -3.99% | 29.71% | 67.17% |
| Total Depreciation and Amortization | 40.98% | 43.05% | 38.06% | 30.56% | 26.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.77% | -29.77% | -48.02% | -144.81% | -318.61% |
| Change in Net Operating Assets | -76.27% | -181.81% | -130.91% | 276.59% | 358.15% |
| Cash from Operations | -40.28% | -58.57% | -53.56% | -12.67% | -16.84% |
| Capital Expenditure | 13.71% | 83.08% | -486.15% | -1,614.55% | -1,752.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.88% | 57.85% | 96.94% | 76.61% | -273,975.93% |
| Cash from Investing | 106.19% | 61.39% | 81.94% | 59.19% | -18,886.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.85% | -12.77% | 99.85% | 99.85% | 99.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,611.97% | 286,851.06% | -74.32% | -101.83% | -101.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.96% | 73.55% | -113.10% | -177.43% | -191.46% |